These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 27192147)

  • 1. Host Immune Responses Differ between M. africanum- and M. tuberculosis-Infected Patients following Standard Anti-tuberculosis Treatment.
    Tientcheu LD; Haks MC; Agbla SC; Sutherland JS; Adetifa IM; Donkor S; Quinten E; Daramy M; Antonio M; Kampmann B; Ottenhoff TH; Dockrell HM; Ota MO
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004701. PubMed ID: 27192147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in T-cell responses between Mycobacterium tuberculosis and Mycobacterium africanum-infected patients.
    Tientcheu LD; Sutherland JS; de Jong BC; Kampmann B; Jafali J; Adetifa IM; Antonio M; Dockrell HM; Ota MO
    Eur J Immunol; 2014 May; 44(5):1387-98. PubMed ID: 24481948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens.
    Kellar KL; Gehrke J; Weis SE; Mahmutovic-Mayhew A; Davila B; Zajdowicz MJ; Scarborough R; LoBue PA; Lardizabal AA; Daley CL; Reves RR; Bernardo J; Campbell BH; Whitworth WC; Mazurek GH
    PLoS One; 2011; 6(11):e26545. PubMed ID: 22132075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
    Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
    Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker.
    Borgström E; Andersen P; Atterfelt F; Julander I; Källenius G; Maeurer M; Rosenkrands I; Widfeldt M; Bruchfeld J; Gaines H
    PLoS One; 2012; 7(11):e43438. PubMed ID: 23144772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy.
    Mattos AM; Almeida Cde S; Franken KL; Alves CC; Abramo C; de Souza MA; L'Hotellier M; Alves MJ; Ferreira AP; Oliveira SC; Ottenhoff TH; Teixeira HC
    Int Immunol; 2010 Sep; 22(9):775-82. PubMed ID: 20624776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential transcriptomic and metabolic profiles of M. africanum- and M. tuberculosis-infected patients after, but not before, drug treatment.
    Tientcheu LD; Maertzdorf J; Weiner J; Adetifa IM; Mollenkopf HJ; Sutherland JS; Donkor S; Kampmann B; Kaufmann SH; Dockrell HM; Ota MO
    Genes Immun; 2015; 16(5):347-55. PubMed ID: 26043170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine response to selected MTB antigens in Ghanaian TB patients, before and at 2 weeks of anti-TB therapy is characterized by high expression of IFN-γ and Granzyme B and inter- individual variation.
    Mensah GI; Addo KK; Tetteh JA; Sowah S; Loescher T; Geldmacher C; Jackson-Sillah D
    BMC Infect Dis; 2014 Sep; 14():495. PubMed ID: 25209422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients infected with Mycobacterium africanum versus Mycobacterium tuberculosis possess distinct intestinal microbiota.
    Namasivayam S; Diarra B; Diabate S; Sarro YDS; Kone A; Kone B; Tolofoudie M; Baya B; Diakite MT; Kodio O; Cohen K; Holl J; Achenbach CJ; Chatterjee S; Murphy RL; Bishai W; Diallo S; Sher A; Maiga M
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008230. PubMed ID: 32401750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacteria-specific cytokine responses as correlates of treatment response in active and latent tuberculosis.
    Clifford V; Tebruegge M; Zufferey C; Germano S; Forbes B; Cosentino L; McBryde E; Eisen D; Robins-Browne R; Street A; Denholm J; Curtis N
    J Infect; 2017 Aug; 75(2):132-145. PubMed ID: 28483404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Frequency of Memory CD4+ T-Cell Responses in Individuals With Previously Treated Extrapulmonary Tuberculosis.
    Barreto-Duarte B; Sterling TR; Fiske CT; Almeida A; Nochowicz CH; Smith RM; Barnett L; Warren C; Blackman A; Lapa E Silva JR; Andrade BB; Kalams SA
    Front Immunol; 2020; 11():605338. PubMed ID: 33391271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of ESAT-6/CFP-10-induced IFN-γ, TNF-α and IL-10 with clinical tuberculosis: evidence from cohorts of pulmonary tuberculosis patients, household contacts and community controls in an endemic setting.
    Abebe F; Belay M; Legesse M; Mihret A; Franken KS
    Clin Exp Immunol; 2017 Aug; 189(2):241-249. PubMed ID: 28374535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium tuberculosis-specific plasmablast levels are differentially modulated in tuberculosis infection and disease.
    Gindeh A; Owolabi O; Donkor S; Sutherland JS
    Tuberculosis (Edinb); 2020 Sep; 124():101978. PubMed ID: 32781412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis.
    Mzinza DT; Sloan DJ; Jambo KC; Shani D; Kamdolozi M; Wilkinson KA; Wilkinson RJ; Davies GR; Heyderman RS; Mwandumba HC
    Tuberculosis (Edinb); 2015 Jul; 95(4):463-9. PubMed ID: 26051653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
    Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
    J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Petruccioli E; Petrone L; Chiacchio T; Farroni C; Cuzzi G; Navarra A; Vanini V; Massafra U; Lo Pizzo M; Guggino G; Caccamo N; Cantini F; Palmieri F; Goletti D
    Front Immunol; 2021; 12():716857. PubMed ID: 34447382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broad adaptive immune responses to M. tuberculosis antigens precede TST conversion in tuberculosis exposed household contacts in a TB-endemic setting.
    Buchwald UK; Adetifa IM; Bottomley C; Owiafe PK; Donkor S; Bojang AL; Sutherland JS
    PLoS One; 2014; 9(12):e116268. PubMed ID: 25549338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversion and conversion of Mycobacterium tuberculosis IFN-gamma ELISpot results during anti-tuberculous treatment in HIV-infected children.
    Connell TG; Davies MA; Johannisen C; Wood K; Pienaar S; Wilkinson KA; Wilkinson RJ; Zar HJ; Beatty D; Nicol MP; Curtis N; Eley B
    BMC Infect Dis; 2010 May; 10():138. PubMed ID: 20507549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ESAT-6 in renal injury by regulating microRNA-155 expression via TLR4/MyD88 signaling pathway in mice with
    Zhou ZQ; Wang ZK; Zhang L; Ren YQ; Ma ZW; Zhao N; Sun FY
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28655852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro- and anti-inflammatory cytokines against Rv2031 are elevated during latent tuberculosis: a study in cohorts of tuberculosis patients, household contacts and community controls in an endemic setting.
    Belay M; Legesse M; Mihret A; Bekele Y; Ottenhoff TH; Franken KL; Bjune G; Abebe F
    PLoS One; 2015; 10(4):e0124134. PubMed ID: 25897840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.